Growth Metrics

Quest Diagnostics (DGX) Non Operating Income (2016 - 2026)

Quest Diagnostics' Non Operating Income history spans 18 years, with the latest figure at -$2.0 million for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 97.14% to -$2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $161.0 million, a 323.68% increase, with the full-year FY2025 number at $26.0 million, down 13.33% from a year prior.
  • Non Operating Income hit -$2.0 million in Q1 2026 for Quest Diagnostics, down from $208.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for DGX hit a ceiling of $208.0 million in Q4 2025 and a floor of -$132.0 million in Q4 2022.
  • Historically, Non Operating Income has averaged -$2.1 million across 5 years, with a median of -$3.0 million in 2023.
  • Biggest five-year swings in Non Operating Income: tumbled 4500.0% in 2022 and later skyrocketed 1290.0% in 2024.
  • Tracing DGX's Non Operating Income over 5 years: stood at -$132.0 million in 2022, then skyrocketed by 107.58% to $10.0 million in 2023, then skyrocketed by 1290.0% to $139.0 million in 2024, then skyrocketed by 49.64% to $208.0 million in 2025, then crashed by 100.96% to -$2.0 million in 2026.
  • Business Quant data shows Non Operating Income for DGX at -$2.0 million in Q1 2026, $208.0 million in Q4 2025, and -$58.0 million in Q3 2025.